Trigen and ProCorde Merge to Create Europe’s First Broad-based Cardiovascular...
Complete pipeline of novel, competitive, clinical-stage products addressing major in-hospital and out-patient thrombosis markets — Extensive portfolio of pre-clinical and discovery-stage programmes and...
View ArticleMagellan Biosciences buys TekCel
Chelmsford’s Magellan Biosciences has acquired TekCel, a Hopkinton-based maker of sample-management and assay-automation systems for biomedical research. Terms of the transaction were not disclosed....
View ArticleNovasite Pharmaceuticals Announces Acquisition of PsyCheNomicS, Inc.;...
SAN DIEGO–(BUSINESS WIRE)–June 15, 2005–Novasite Pharmaceuticals Inc., a company focused on the discovery and development of allosteric modulators of G-protein coupled receptors (GPCRs), today...
View ArticleFisher acquires Oakland company
Cellomics Inc., hailed as one of Pittsburgh’s most promising life science start-up companies, has been acquired by Fisher Scientific International Inc., a firm with century-old Pittsburgh roots....
View ArticleGalapagos Announces Third Quarter 2005 Results
— Acquisition of BioFocus completed, integration progresses as planned — Galapagos year to date revenues 8% below last year’s revenues, but cash burn in line with forecast — Revenue guidance for 4Q ’05...
View ArticleBioServe Acquires Genomics Collaborative
BioServe Extends Genomics Services Platform with Premier Industrial Biobank for Biomarker Discovery and Validation Beltsville, MD, May 1st, 2007 – BioServe, a leading provider of genomics services,...
View ArticlePreclinical services news in brief – In this week’s review of activity within...
Belgian biopharma firm UCB has this week selected ZoBio to provide ligand screening services for some of its targets in the field of fragment-based drug discovery. ZoBio will undertake this task using...
View ArticleMichigan High Throughput Screening Center and NSF International Announce New...
ANN ARBOR, MI and KALAMAZOO, MI, July 31, 2007– Global Lifescience Solutions, an NSF International Company offering contract research services to the biotechnology and pharmaceutical industries, today...
View ArticleUpstream Biosciences Acquires Innovative Platform Technology and Drug...
-Acquisition of Pacific Pharma Technologies Brings Proprietary Artificial Intelligence-Based Drug Discovery Platform and Novel Drug Candidates to Upstream–Initial Compounds Demonstrate Promising In...
View ArticleCompany and People Notes: Patheon and Solvias Form Alliance; AstraZeneca...
Nov 20, 2008 ePT–the Electronic Newsletter of Pharmaceutical Technology Company Notes San Jose, CA (Nov. 14)—AnaSpec established a new facility dedicated to peptide production that complies with good...
View ArticleForget the Shortcuts: Creating a Truly Innovative Biotech Culture
Watching the acquisition of Genentech by Roche has been a fascinating process. I wasn’t so interested in the eventual price paid per share, but whether Basel, Switzerland-based Roche, one of the...
View ArticleSigma-Aldrich buys ChemNavigator
Sigma-Aldrich said Thursday that it acquired ChemNavigator.com Inc., a provider of software used to identify and procure chemistry needed for drug discovery and research, for an undisclosed sum....
View ArticleAlcon to Acquire Swiss Biotechnology Firm, ESBATech AG Company gains access...
HUENENBERG, Switzerland & ZURICH, Sep 13, 2009 (BUSINESS WIRE) — –Acquisition establishes sustainable platform for ongoing biologics development –Deal builds on other recent transactions to expand...
View ArticleEurogentec Announces Agreement to Acquire AnaSpec, Inc.
Liège, Belgium—October 23, 2009. Eurogentec S.A. (“Eurogentecâ€) announces today a final agreement for the acquisition of AnaSpec Inc (“AnaSpec†or the “Companyâ€), a privately held...
View ArticleCommonwealth Biotechnologies, Inc. Acquisition of GL Biochem: Market Update
Shareholders approve sale of the Richmond, Virginia assets as required under the GL Biochem Asset Purchase Agreement RICHMOND, Va.–(Business Wire)– Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ...
View Article2009: The Year That Was For Pfizer
(RTTNews) – True to expectations, Jeffrey Kindler, the CEO of Pfizer Inc. (PFE | Quote | Chart | News | PowerRating), scripted a new playbook for the drug giant in 2009, accelerating the process of...
View ArticleSanofi-aventis’ purchase aligned with technology ‘coming of age’
Sanofi-aventis’ acquisition of the pharmaceutical development company that began as Selectide is “coincident with the technology, essentially, coming of age,” according to Tucson Research Center...
View ArticleActelion obtains option to acquire privately-held Trophos
Late-stage Phase III compound in Amyotrophic Lateral Sclerosis to report data in late 2011 – Novel therapeutic approach to be further explored in drug discovery collaboration ALLSCHWIL, SWITZERLAND and...
View ArticleIllumina’s New Sequencers
The genetics world was rocked by a surprise announcement from its most prominent company: Illumina is secretly owned by Apple. At least, that would explain the company’s obvious joy at making their...
View Article
